SaMD FOR PHARMA

Clinical outcomes. Improved

Huma’s EU MDR  Class IIb regulated software as a medical device platform enables faster, smarter symptom tracking and clinical decision-making, resulting in earlier interventions, better patient experiences and improved outcomes.

With a single view of the patient on one convenient dashboard, clinicians can identify at-risk patients earlier and make timely interventions sooner—especially for patients with multiple comorbidities.

Improve clinical outcomes

90-95%

adherence and retention rates across our care and research deployments are the result of high engagement rates1

x2

Our platform can almost double clinical capacity and reduce readmission rates by >30%2

3-4x

lower mortality amongst Huma patients compared with patients not using Huma3

88.2%

of patients highlighted as deteriorating had operation dates brought forward4

AGGREGATE. ASSESS. ACT

Positively impact patient health outcomes with smart insights

Huma’s scalable platform gives you access to aggregated data in one convenient dashboard, including digital biomarker data and ePROs. Clinician-configurable RAG indicators help to quickly flag patients in need of treatment review or intervention.

Higher acuity patients at risk of deterioration can be monitored remotely on the platform for a longer period of time, rather than simply escalating all at-risk patients to the ED.

Our platform provides personalised and adaptive direction on treatment interventions, leveraging processed input data, including novel AI-driven algorithms and digital biomarkers.

Huma clinician app screenshot.
Huma clinician app screenshot.
Huma clinician app screenshot.
Huma clinician app screenshot.
AGGREGATE. ASSESS. ACT

Positively impact patient health outcomes with smart insights

Huma’s scalable platform gives you access to aggregated data in one convenient dashboard, including digital biomarker data and ePROs. Clinician-configurable RAG indicators help to quickly flag patients in need of treatment review or intervention.

Higher acuity patients at risk of deterioration can be monitored remotely on the platform for a longer period of time, rather than simply escalating all at-risk patients to the ED.

Our platform provides personalised and adaptive direction on treatment interventions, leveraging processed input data, including novel AI-driven algorithms and digital biomarkers.
Huma clinician app screenshot.
Huma clinician app screenshot.
CLINICAL DECISIONS. SUPPORTED

Make informed clinical decisions across teams

Huma’s remote patient monitoring platform enables multiple teams and specialists to review patient data and clinician notes in a single platform, enabling improved clinician collaboration.

Data visualisation and overlay tools give clinicians dynamic information to help uncover patient insights. Our platform displays aggregated risk scores (e.g. NEWS2), allowing rapid prioritisation and patient triage.

Huma clinician app screenshot.
Huma clinician app screenshot.
AGGREGATE. ANALYSE. ACT

Make informed clinical decisions across teams

Huma’s remote patient monitoring platform enables multiple teams and specialists to review patient data and clinician notes in a single platform, enabling improved clinician collaboration.

Data visualisation and overlay tools give clinicians dynamic information to help uncover patient insights. Our platform displays aggregated risk scores (e.g. NEWS2), allowing rapid prioritisation and patient triage.
OUTCOMES. OPTIMIZED

Improve outcomes across therapeutic areas

Huma’s EU MDR Class IIb regulated platform accommodates disease-specific configurations across diabetes, heart failure, cardiovascular disease, asthma, and many more therapeutic areas.

You can now monitor and support patients with multiple co-morbidities in order to better assess patient wellbeing. Huma provides smart, interactive, remote patient monitoring and symptom tracking support for a greater range of patients—including those with higher acuity conditions and comorbidities.

Regulatory, safety and compliance

CE 0297 icon.
EU MDR 2017/745 Class IIb certified

MHRA registered Medical Device Class IIb

US FDA icon.
US FDA 21 CFR compliances Class I exempt and under enforcement discretion

Part 11

Part 50

Part 820 ff

ISO icon.
ISO certifications

ISO 13485: 2016 certified (Medical Devices: Quality Management Systems)

ISO 27001: 2013 certified

Data protection - infosec icon.
Data protection / infosec

Committed to GDPR compliance

NHS Registration on Data Security and Protection Toolkit

CyberEssentials / CyberEssentials Plus

Request a meeting

This field is required
This field is required
This field is required
This field is required
Country/Region ⃰
This field is required
I'm interested in

Huma is committed to respecting your privacy, and we’ll only use your personal details to provide information you have selected you’re interested in. Review our Privacy Policy for further information.

We’d love to send you our monthly newsletter about our latest work, research and events by email. We’ll always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes.

Submit
Thank you.
We will be in touch with you shortly.
Oops! Something went wrong while submitting the form.